Results 61 to 70 of about 11,687 (218)

Indications and opportunities for transsplenic access to treat portal venous and portosystemic pathology: A report of 2 cases and review of the literature

Radiology Case Reports
Transsplenic access has emerged as a valuable technique for portal venous interventions when conventional transjugular or transhepatic approaches are challenging due to prohibitive anatomy.
Trinity Puno, BS, Joshua Levy, MD, Daniel Villegas, MD, Marvi Moreno, MD, Ryan Rimer, MD, Brandon Chen, MD   +5 more
doaj   +1 more source

Endovascular Management of Hepatic Encephalopathy

Journal of Clinical Interventional Radiology ISVIR, 2021
Transjugular intrahepatic portosystemic shunt (TIPS) and spontaneous portosystemic shunts (SPSS) may lead to new or worsening hepatic encephalopathy (HE), especially in patients with chronic liver disease.
Hieu Le, Siddhant Thukral, A. Michael Devane, Souheil Saddekni, Rakesh K. Varma   +4 more
doaj   +1 more source

Hepatic infarction following abdominal interventional procedures. [PDF]

, 2004
To clarify the incidence, background, and progress of hepatic infarction following interventional procedures, cases of hepatic infarction following interventional procedures at our department during the last decade were identified by reviewing the ...
Akaki, Shiro, Fujiwara, Hiroyasu, Hiraki, Takao, Hiraki, Yoshio, Kanazawa, Susumu, Mimura, Hidefumi, Naomoto, Yoshio, Tanaka, Noriaki, Yagi, Takahito, Yasui, Kotaro   +9 more
core   +1 more source

Sarcopenia Is Associated With Mortality and Progression of Cirrhosis in Decompensated but Not Compensated Disease—A Multicentre Study

Alimentary Pharmacology &Therapeutics, EarlyView.
In a retrospective cohort of 1,624 adults with cirrhosis, sarcopenia was independently associated with unplanned hospitalization, death, and cirrhosis progression (or death) in patients with decompensated disease. In compensated cirrhosis, sarcopenia was associated only with a higher risk of unplanned hospitalization.
Puneeta Tandon, Sarah Wang, Moon Young Kim, Bart Van Hoek, Daphne Bot, Jeroen L. A. van Vugt, Berend Beumer, Jan Ijzermans, Sunil Taneja, Ajay Duseja, Surender Singh, Maryam Ebadi, Aldo J. Montano‐Loza   +12 more
wiley   +1 more source

Safety and Efficacy of Overdilation of 10 mm Viatorr Transjugular Intrahepatic Portosystemic Shunt Stents Using 12 mm Balloons

The Arab Journal of Interventional Radiology
Objective The aim of this study was to evaluate overdilation of 10-mm standard and 8–10 mm controlled-expansion Viatorr stents to 12 mm during transjugular intrahepatic portosystemic shunt (TIPS) placement when insufficient reduction (
Muhammad Mohid Tahir, Trevor K. Lewis, Aamir Ali, Michael Hsu, Jeffrey L. Weinstein, Muneeb Ahmed, Ammar Sarwar   +6 more
doaj   +1 more source

Transjugular intrahepatic portosystemic shunt (TIPS); review of initial experience at Aga Khan University Hospital [PDF]

, 2011
OBJECTIVE: To retrospectively assess the therapeutic effectiveness and safety of transjugular intrahepafic portosystemic shunt (TIPS) in patients with portal hypertension related complications.
Azeemuddin, Muhammad, Chishti, Ishtiaq, Hamid, Rana Shoaib, Sajjad, Zafar, Salam, Basit, Tanveer-ul-haq,   +5 more
core   +1 more source

Animal Naming Test Can Identify Covert Hepatic Encephalopathy in Patients With Cirrhosis With Limited Influence From Age or Educational Level

Hepatology Research, EarlyView.
Adjustments for age and educational level in animal naming test cause patients’ discomfort and limit its use in clinical practice. In our study, animal naming test was useful in identifying covert hepatic encephalopathy and its adjustment using age and educational level had limited incremental value the diagnostic ability.
Takao Miwa, Shinji Unome, Sachiyo Hirata, Satomi Nakashima, Kayoko Nishimura, Yoshiyuki Miwa, Teruo Maeda, Masashi Aiba, Masahito Shimizu   +8 more
wiley   +1 more source

Ammonia : this is not the end but rather the end of the beginning [PDF]

, 2018
Hepatic encephalopathy (HE) represents a wide spectrum of neurological or neuropsychological symptoms caused by liver disease and/or portosystemic shunts.
Dam, Gitte, Rose, Christopher, Weiss, Nicolas   +2 more
core   +1 more source

Low‐Dose vs. Standard Care Iv Human Albumin During Large‐Volume Paracentesis in Patients With Liver Cirrhosis: A Systematic Review

Liver International, Volume 46, Issue 5, May 2026.
ABSTRACT Cirrhosis is a global health concern, with ascites being the most prevalent decompensating event. Intravenous (IV) human albumin (HA) is administered during large‐volume paracentesis (LVP) to prevent complications. The standard (6–8 g HA/L ascites) is empirically chosen, potentially leading to overtreatment and added costs.
Kimberly K. I. M. Bot, Roebi Heus, Joost P. H. Drenth, Marten A. Lantinga   +3 more
wiley   +1 more source

Massive avascular malformations causing life threatening portal hypertension

Annals of Hepatology, 2012
We present an unusual case of extensive avascular malformations (AVMs) causing non-cirrhotic portal hypertension. This phenomenon, though previously described, is a rare clinical entity which, in the setting of life threatening portal hypertension, may ...
Aman Arya, Nirmal Kakani, Nabil Hussain, Natasha Chandok   +3 more
doaj   +1 more source